Detalhe da pesquisa
1.
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Lancet
; 402(10404): 798-808, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451295
2.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Lancet
; 400(10358): 1117-1129, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099927
3.
Melanoma care during one year pandemic in Berlin: decreasing appointment cancellations despite increasing COVID-19 concern.
J Dtsch Dermatol Ges
; 20(7): 962-978, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665996
4.
Melanomversorgung während eines Jahres Pandemie in Berlin: abnehmende Terminstornierungen trotz zunehmender Besorgnis über COVID-19.
J Dtsch Dermatol Ges
; 20(7): 962-979, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881087
5.
Patient preferences for treatment of advanced melanoma: impact of comorbidities.
J Dtsch Dermatol Ges
; 19(1): 58-70, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33015933
6.
Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab.
Future Oncol
; 16(27): 2089-2099, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938212
7.
Crucial role of reactive oxygen species (ROS) for the proapoptotic effects of indirubin derivative DKP-073 in melanoma cells.
Mol Carcinog
; 58(2): 258-269, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30320471
8.
Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.
Exp Dermatol
; 28(1): 35-44, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326165
9.
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.
Br J Cancer
; 118(6): 785-792, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438368
10.
Patientenpräferenzen für die Therapie fortgeschrittener Melanome: Einfluss von Komorbidität.
J Dtsch Dermatol Ges
; 19(1): 58-72, 2021 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-33491889
11.
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma.
J Transl Med
; 13: 351, 2015 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541511
12.
Regional nodal relapse in surgically staged Merkel cell carcinoma.
Strahlenther Onkol
; 191(1): 51-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25293726
13.
Laser capture microdissection provides a novel molecular profile of human primary cutaneous melanoma.
Pigment Cell Melanoma Res
; 37(1): 81-89, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776566
14.
COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma.
Cancers (Basel)
; 15(18)2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760406
15.
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
J Immunother Cancer
; 11(9)2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37730278
16.
Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I-III patients.
Eur J Cancer
; 143: 11-18, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278769
17.
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301810
18.
Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
Eur J Cancer
; 152: 139-154, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102453
19.
Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition.
Eur J Cancer
; 148: 61-75, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735811
20.
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts.
J Clin Oncol
; 38(22): 2543-2551, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32530760